MOUNJARO FOR WEIGHT LOSS IN PHILADELPHIA
The World Health Organization (2024) reported that one out of eight people are now living with obesity. Particularly in the US, where Philadelphia has one of the highest rates of obesity in the country according to the CDC. They say 67% of adults in the city are overweight. With obesity rates rising and traditional weight loss methods often proving ineffective for some individuals, we at Avellina Aesthetics offer solutions like Mounjaro, a groundbreaking medication initially designed for the treatment of Type 2 diabetes but now recognized for its impressive weight loss capabilities.
Given that obesity is still a public health concern and is linked to metabolic health issues like kidney health, blood sugar regulation problems, and cardiovascular disease, Mounjaro Injections presents a viable long-term, sustainable weight management strategy.
WHAT IS MOUNJARO?
Mounjaro (Tirzepatide) is a dual-agonist injectable medication that activates two key receptors – the GLP-1 receptor (glucagon-like peptide-1) and the GIP receptor (glucose-dependent insulinotropic polypeptide). Initially approved by the FDA as a diabetes drug for managing Type 2 diabetes, Mounjaro’s ability to reduce body weight was quickly recognized in clinical trials.
he medication’s special dual receptor activation affects both appetite regulation and metabolic processes, which helps diabetic patients lose a significant amount of weight in addition to managing their A1c levels.
Aside from that main function, Mounjaro can also benefit the following:
Cardiovascular Benefits and Kidney Health
Tirzepatide has the potential to enhance both cardiovascular health and weight loss outcomes, which is one of its additional advantages. Mounjaro has been demonstrated in clinical trials to lower two major heart disease risk factors, blood pressure and cholesterol. Additionally, this medicine enhances kidney function, which is critical for individuals with Type 2 diabetes as it usually leads to renal issues.
Microbiome Influence and Genetic Factors
According to recent studies, the effectiveness of Mounjaro shot for weight loss may be significantly influenced by the microbiome and hereditary components of obesity. A more effective solution for chronic weight management is provided by Mounjaro, which targets the brain-gut connection in patients who struggle with their weight due to genetic factors. Some patients may have biological predispositions that make losing weight more difficult.
IS MOUNJARO FDA-APPROVED FOR WEIGHT LOSS?
On its initial release, Mounjaro is FDA-approved for managing Type 2 diabetes but is not yet specifically approved for obesity treatment. However, in November 2023, a new version of the popular diabetes treatment was FDA-approved as a weight-loss drug. Mounjaro weight loss injections were further supported by clinical trials like SURMOUNT-1 which shown that patients taking Tirzepatide for weight loss saw a reduction in BMI by up to 22.5% over 72 weeks, outperforming Wegovy and Ozempic (both based on semaglutide) as medication for weight loss in Philadelphia.
The FDA also emphasized that this approved Lilly’s drug for people who are considered obese, should be paired with a healthy diet and regular exercise. Additionally, the drug is beneficial for people with adiposity-based chronic diseases, including high blood pressure, high cholesterol, and diabetes.
WHAT IS THE USUAL DOSAGE FOR MOUNJARO?
Mounjaro has become a viable bariatric surgery alternative for many patients seeking non-invasive yet effective treatment options. Yet, it is crucial to understand the correct intake dosage to minimize its side effects including nausea, diarrhea, and abdominal pain when increasing the dose.
It is important to remember that this medicine takes effect every four weeks, with a 15 mg weekly dose as the maximum. Mounjaro’s dose is increased gradually according to your tolerance and response. Thus, this is better taken at the lowest starting dose possible, then progressively increased as follows:
Weeks 1 – 4: 2.5 mg
Weeks 4 – 8: 5 mg; if you are still losing weight, you can continue this dosage.
Weeks 8–12: 7.5 mg
Weeks 12 -16: 10 mg; if you are still losing weight, you can continue this strength.
Weeks 16–20: 12.5 mg
Weeks 20 and beyond: 15 mg – continue this dosage if you are still losing weight
HOW DOES MOUNJARO WORK?
Mounjaro is administered via subcutaneous injection and works by mimicking the actions of GLP-1 and GIP hormones, which are responsible for controlling insulin, blood sugar, and appetite. The injection for weight loss, Mounjaro, slows down the emptying of the stomach and encourages signals from the brain-gut connections that make people feel full even after consuming smaller amounts of food. It also improves how the body responds to insulin, which helps with weight loss and promotes better metabolic health.
Notably, the dual-agonist approach has benefits over GLP-1 receptor standard medications, which explains why Mounjaro is particularly effective in reducing blood sugar and body weight. But for better results, always monitor a reduced-calorie diet and regular physical exercise.
Can You Take Wegovy and Mounjaro Together?
While both Wegovy (semaglutide for weight loss) and Mounjaro are injectable medications used for weight loss, they are not recommended to be taken together. Both drugs target the GLP-1 receptor and combining them could increase the risk of gastrointestinal side effects such as nausea, vomiting, and diarrhea, while also posing risks of hypoglycemia. Given their different mechanisms of action—Mounjaro’s dual targeting receptors—it’s best to consult with a healthcare provider to determine which medication is right for you.
How Effective is Mounjaro?
In clinical trials, Mounjaro has demonstrated remarkable results; participants have lost an average of 48.9 to 52 pounds, a substantial amount more than most weight-loss drugs currently on the market. A 2022 study by Dr. Jastreboff found that people using tirzepatide experienced weight loss within weeks, depending on the dosage and body’s ability to manage higher doses. The study targeted individuals with a BMI greater than 30 or 27 with one weight-related complication, excluding diabetes.
Over 72 weeks, those using 10 mg lost an average of 19.5% of their weight, while those using 15 mg lost 20.9%. With regards to maintaining weight over the long term and lowering the health risks associated with obesity, this result establishes Mounjaro as one of the best choices. The medication’s capacity to reset metabolic set points guarantees more sustainable weight loss and may have long-term effects on body weight regulation.
NEED MOUNJARO INJECTIONS IN PHILADELPHIA? CONTACT AVELLINA AESTHETICS TODAY
If you’re considering Mounjaro injections to help you achieve your weight loss goals, Avellina Aesthetics is here to support you every step of the way. As a leading rejuvenation clinic and weight loss, we offer individualized care that is catered to your specific health needs in addition to state-of-the-art procedures like Mounjaro.
Because we are aware that expenses and insurance coverage may raise questions, we carefully consider all of our patients’ options. In order to help you receive the treatment you need at a price that works for you, Avellina Aesthetics offers cost-effective pricing options and assistance navigating insurance coverage. Take the first step toward a healthier future today—contact Avellina Aesthetics at 215-722-6022 to schedule your consultation.